Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BRD8 |
| Upstream (Parents) |
|---|
| (<<) EGR4 → BRD8 |
| (<<) DMRT1 → BRD8 |
| (<<) SOX30 → BRD8 |
| (<<) NEUROD2 → BRD8 |
| (<<) OLIG2 → BRD8 |
| (<<) TADA2A → BRD8 |
| (<<) SMAD3 → BRD8 |
| (<<) SMAD9 → BRD8 |
| (<<) MLXIPL → BRD8 |
| (<<) SIX5 → BRD8 |
| (<<) ZBTB17 → BRD8 |
| (<<) C11orf9 → BRD8 |
| (<<) HMX1 → BRD8 |
| (<<) SATB1 → BRD8 |
| (<<) HOXC4 → BRD8 |
| (<<) HOXC13 → BRD8 |
| Downstream (Children) |
|---|
| BRD8 → PRDM2 (>>) |
| BRD8 → ZIC3 (>>) |
| BRD8 → IKZF1 (>>) |
| BRD8 → NFKB2 (>>) |
| BRD8 → SCAND2 (>>) |
| BRD8 → NFATC1 (>>) |
